In particular, IKKβ, a key protein leading to NFκB activation, is downregulated in high-grade glioma, and downregulation of IKKβ is correlated with immunosuppressive gene signatures in tumors (Mieczkowski et al., 2015). This evidence concerns the gene IKBKB and central nervous system cancer.